BiosciNews

Founded in 2002, ENS@T aims to improve the understanding of the genetics, tumorigenesis and hypersecretion in patients with adrenal tumors and syndromes and to improve the prediction of recurrences and the management of malignant tumors. Because adrenal tumours are rare, they do not benefit from well controlled therapeutic trials with new drugs. To tackle this problem the project aims to bring the issue to a wider European level. Visit the website for further information.

Rare diseases project profile: Ens@t - The European Network for the Study of Adrenal Tumors

Share this story

Top stories

Most read